43.05 0.00 (0.00%)
After hours: 4:30PM EDT
|Bid||43.13 x 1000|
|Ask||43.18 x 2900|
|Day's Range||42.92 - 44.15|
|52 Week Range||35.03 - 85.75|
|Beta (3Y Monthly)||0.67|
|PE Ratio (TTM)||19.42|
|Earnings Date||Nov 5, 2019 - Nov 11, 2019|
|Forward Dividend & Yield||1.48 (3.36%)|
|1y Target Est||49.44|
Nu Skin (NUS) is battling headwinds in Mainland China, stemming from the government's campaign to scrutinize offerings of direct selling and health products industries.
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and -1.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
PROVO, Utah , Aug. 6, 2019 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second-quarter 2019 results. Executive Summary Q2 2019 vs. Prior-Year Quarter Revenue: $623.5 million; ...
PROVO, Utah , Aug. 6, 2019 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.37 per share, which will be paid on ...
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll apply a...
Nu Skin's (NUS) Q2 performance is likely to be hurt by the government campaign in Mainland China to inspect offerings of direct selling industries and health products.
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Nu Skin Enterprises...
Nu Skin Enterprises, Inc. (NYSE: NUS ) shares are in free fall mode after reporting weak preliminary second-quarter earnings guidance . Nu Skin also cut its preliminary 2019 sales guidance . The Analyst ...
Nu Skin Enterprises Inc. stock plummeted 16.4% in Wednesday trading after the health, wellness and beauty company cut its guidance due to problems in the Chinese market. Nu Skin was also downgraded to neutral from buy at D.A. Davidson after the news. Nu Skin now expects second-quarter revenue of $622 million to $623 million, below the $630 million FactSet consensus. Earnings per share are expected to be 82 cents to 84 cents. The FactSet consensus is for 84 cents. "We are adjusting our guidance for the year primarily due to a reduced revenue outlook in Mainland China following the government's 100-day campaign to review and inspect the health products and direct selling industries," said Nu Skin Chief Executive Ritch Wood in a statement."Continued restrictions on sales meetings, as well as media scrutiny, have negatively impacted consumer sentiment and contributed to this adjustment." D.A. Davidson notes that China revenue accounted for 33% of Nu Skin's 2018 total. Analysts slashed the price target by $50, bringing it down to $38 from $88. However, they are bullish for the long term; they expect the dividend to be safe and think the company will make an adjustment if its meetings continue to be curtailed. "If the meeting ban continues for a long period of time, we think Nu Skin could develop alternative methods to lessen the magnitude of sales declines," analysts said. Stifel analysts also cut their Nu Skin price target to $37 from $45 and maintained their sell stock rating. Nu Skin stock has fallen nearly 50% over the last year while the S&P 500 index has gained 6.6%.
Nu Skin's (NUS) Q2 and 2019 results are likely to be hurt by weak performance in China, triggered by government's product review initiatives.
Nu Skin Enterprises Inc. shares fell in the extended session Tuesday after the beauty and wellness products maker cut its outlook. Nu Skin shares fell 14% after hours, following a 3.4% rise to close the regular session at $45.51. The company forecast earnings of 82 cents to 84 cents a share on revenue of $622 million to $623 million for the second quarter, and $3.20 to $3.25 a share on revenue of $2.48 billion to $2.52 billion for the year. Analysts surveyed by FactSet had estimated earnings of 93 cents a share on revenue of $672.5 million for the second quarter, and $3.94 a share on revenue of $2.77 billion for the year. "We are adjusting our guidance for the year primarily due to a reduced revenue outlook in Mainland China following the government's 100-day campaign to review and inspect the health products and direct selling industries," said Nu Skin Chief Executive Ritch Wood in a statement. "Continued restrictions on sales meetings, as well as media scrutiny, have negatively impacted consumer sentiment and contributed to this adjustment."
PROVO, Utah, July 16, 2019 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NUS) today announced estimated second-quarter results and updated its outlook for full-year 2019. The company anticipates reporting second-quarter revenue between $622 and $623 million and earnings per share of $0.82 to $0.84. The company's revised revenue outlook for 2019 is $2.48 to $2.52 billion with a negative foreign currency impact of approximately 4 percent, and earnings per share of $3.20 to $3.35.
Nu Skin's (NUS) customer base rises steadily, courtesy of effective marketing strategies and launches. However, adverse impacts of currency rates are concerns.
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Nu Skin Enterprises...
PROVO, Utah, June 20, 2019 /PRNewswire/ -- Nu Skin has been recognized by Forbes magazine as one of America's Best Employers in Utah for 2019. The company has consistently been recognized as a top employer in its industry and its markets around the world, and this recognition is part of Forbes' inaugural listing of Best Employers by State. "As Nu Skin has grown the past 35 years into a multi-billion-dollar, global company, we have continually strengthened our enriching and uplifting culture and family-like atmosphere that are the core of who we are," said Ritch Wood, CEO.